Womens Health

FDA Debates Future of Breast Cancer Drug Avastin

| by Mark Berman Opposing Views

The best-selling cancer drug in the world comes under federal scrutiny once again this week, as the FDA hears arguments to keep Avastin approved for breast cancer treatment. More from the Associated Press: